U.S. Life Sciences Stock News

Earlier this month, Credo Technology Group Holding reported substantial growth in both revenue and net income, and projected more than US$800 million in revenue for 2026, signaling an upward shift in its business outlook. This outlook highlights strong future demand for Credo's high-speed connectivity solutions and a boost in investor confidence regarding the company's financial trajectory. We'll explore how robust revenue and net income growth could reshape Credo's long-term investment...

Integral Ad Science Holding Corp. recently reported second quarter 2025 results, with revenue rising to US$149.2 million and net income reaching US$16.41 million, both up from the previous year, and raised its full-year revenue guidance to a range of US$597 million to US$605 million. The company also became the first in its industry to earn the Ethical AI Certification from the Alliance for Audited Media, highlighting its commitment to responsible AI practices across its ad measurement...

Last week, Select Medical Holdings Corporation announced amendments to its bylaws to clarify procedures for shareholder nominations and proposals, alongside reporting second-quarter financial results that included revenue growth but reduced net income year over year. A one-off US$29 million expense and mixed performance in the Rehabilitation Hospital segment featured prominently, despite management reaffirming annual financial guidance and continuing with dividends and share...

Verb Technology Company announced a sweeping overhaul in leadership and governance in early August 2025, appointing Veronika Kapustina as CEO and Sarah Olsen as CFO/COO, while simultaneously completing a very large private placement raising over US$550 million from prominent institutional and crypto-native investors. This confluence of management change and significant new funding marks a potential shift in the company’s direction, as Verb gains both new capital resources and leadership...

Solventum Corporation recently reported second-quarter 2025 results that exceeded analyst estimates, including revenue of US$2.16 billion and adjusted earnings per share of US$1.69, prompting an increase in its full-year guidance for both organic sales growth and earnings per share. The company highlighted ongoing progress in its separation from 3M and successful execution of operational initiatives, with particular strength seen across surgical equipment and multiple other business...

In July 2025, TTM Technologies announced the retirement plans of CEO Thomas T. Edman, outlined the search for his successor, and reported achievement of Cybersecurity Maturity Model Certification (CMMC) Level 2, confirming compliance with U.S. Department of Defense cybersecurity requirements. This CMMC Level 2 certification strengthens TTM’s credentials for securing defense contracts and underscores its operational focus on key regulated sectors. We’ll now explore how TTM’s new CMMC Level 2...

Hawkins, Inc. recently reported its first quarter 2025 results, showing increased sales to US$293.27 million and a 6% dividend boost, and also announced CEO and CFO participation at Seaport Research Partners' investor conference this August. The company additionally ratified Deloitte & Touche LLP as its independent auditor for the fiscal year, signaling ongoing focus on governance and transparency. We'll now explore how Hawkins' strong quarterly earnings and dividend growth shape its current...

Merchants Bancorp recently reported its second quarter 2025 results, revealing US$46.1 million in charge-offs across 14 multi-family loan customers and no recoveries, alongside a significant year-over-year drop in net income and earnings per share. This marks a considerable increase in loan losses compared to previous quarters and suggests growing pressure on the bank's credit quality and profitability. We’ll explore how elevated charge-offs in the multi-family loan portfolio shape the...

In July 2025, Elevance Health announced that Steve Collis, Executive Chairman of Cencora and respected healthcare industry leader, has joined its board of directors and will serve on the Audit and Finance Committees, effective August 1. This appointment bolsters Elevance's board-level financial oversight and industry expertise at a time when the company is addressing evolving business strategy and stakeholder demands in the healthcare sector. We'll examine how the addition of Steve Collis...

CNO Financial Group recently declared a quarterly cash dividend of US$0.17 per share and completed a US$57.50 million shelf registration for a 1,600,000 share ESOP-related common stock offering, alongside reporting quarterly earnings and share repurchases. The company’s coordinated capital management activities, including dividends, repurchases, and equity offerings, reflect a multifaceted approach to returning value and managing growth. We will explore how CNO’s continued dividend payments...

Wall Street recently anticipated that DLocal would report a year-over-year drop in earnings for Q2 despite higher revenues, ahead of the company’s August 13 results announcement. High insider ownership at 49% and a history of annual EPS growth suggest strong management conviction, even as EBIT margins have declined. We will now examine how increased analyst optimism amid revenue growth shapes DLocal’s investment narrative going forward. The end of cancer? These 26 emerging AI stocks are...

Coastal Financial Corporation recently announced second quarter 2025 results, reporting net interest income of US$76.74 million and net income of US$11.03 million, both down from the previous year, along with net charge-offs of US$49.3 million. Despite ongoing growth in its Banking as a Service (BaaS) segment, persistent charge-offs and lower earnings per share have sparked concerns over the bank’s profitability trajectory. We'll examine how lower net income alongside high charge-offs shapes...

Corcept Therapeutics recently reported its second quarter 2025 financial results, revised full-year revenue guidance to US$850–US$900 million, and completed a substantial share buyback program totaling more than US$146 million as of June 30, 2025. The company's updates highlight ongoing profitability, management confidence, and efforts to support future growth through operational expansion and vendor partnerships. We’ll explore how Corcept’s raised revenue guidance, fueled by its expanding...

Between April and June 2025, Thermo Fisher Scientific repurchased no shares, completing its buyback program with 5,527,770 shares repurchased for US$3.00 billion under its November 2024 authorization. This period also saw analysts revising down near-term sales and earnings expectations due to tariff issues and reduced U.S. research funding, while highlighting improved growth from biopharma clients and historically low valuation levels for the company. To better understand how ongoing tariff...

Innodata Inc. recently reported robust second-quarter 2025 results, highlighted by sales of US$58.39 million and net income of US$7.22 million, and subsequently raised its full-year 2025 organic revenue growth guidance to at least 45% from the previous 40% forecast. The company’s shift from traditional data provision toward comprehensive AI model evaluation, trust and safety, and simulation services reflects its wider ambitions within the rapidly evolving AI ecosystem. We will now explore...

In recent days, NXP Semiconductors introduced its i.MX 95 series processors, designed for advanced automotive, industrial, and AI-driven applications, featuring cutting-edge machine learning and 3D graphics capabilities. An interesting insight is that NXP's operational efficiencies have enabled it to significantly increase its return on capital while keeping its capital base steady, highlighting improved profitability from existing resources. We'll now examine how product innovation in AI...

ICF International recently launched ICF Fathom, a suite of artificial intelligence solutions designed to speed up results and streamline federal agency operations, offering secure integration and a wide range of configurable AI agents for key government functions. This rollout signals ICF’s growing emphasis on AI-enabled services, further setting it apart in the federal technology consulting market and supporting its client-focused innovation strategy. We’ll examine how ICF Fathom’s...

Somnigroup International recently announced the declaration of a US$0.15 per share third quarter cash dividend and reported its second quarter 2025 earnings, with sales rising to US$1.88 billion but net income declining compared to the prior year. The company also expanded its partnership with Fullpower-AI through a US$25 million equity investment and multi-year technology deal, emphasizing ongoing innovation in sleep solutions. Next, we'll explore how the technology investment with...

Hercules Capital recently reported its second quarter 2025 results, highlighting year-over-year increases in revenue to US$137.46 million and net income to US$78.89 million, along with the declaration of a US$0.47 per share total cash distribution comprised of both regular and supplemental dividends. These results reflect the company's ability to continue growing and distributing cash to shareholders, even as the broader commercial finance industry faces persistent high interest rates and...

HA Sustainable Infrastructure Capital, Inc. recently reported its second quarter 2025 financial results, with revenue of US$85.69 million and net income of US$98.45 million, both measured against figures from the previous year. Despite higher net income, the company faced a revenue decline and missed analyst expectations for both revenue and earnings per share, highlighting a disconnect that has drawn investor attention. We'll examine how the revenue shortfall, despite increased net income,...

Earlier this month, Universal Corporation reported first quarter results showing net income rising to US$8.5 million from US$130,000 a year earlier, with basic earnings per share climbing to US$0.34 on slightly lower sales of US$593.76 million. This performance was driven by a favorable product mix in the Tobacco Operations segment and renewed growth initiatives in the Ingredients segment, reflecting an increased focus on value-added and sustainable products. We'll explore how this robust...

Baidu (BIDU) just made waves with its announcement of a new strategic partnership with Lyft, aiming to bring its Apollo Go autonomous vehicles to Europe starting in 2026. For investors who have watched Baidu’s core advertising business struggle in recent years, this is a bold signal of the company’s ambition to find new growth engines. The rollout will begin in the UK and Germany and eventually scale across the continent. This marks a clear push by Baidu to tap into the fast-evolving world of gl

Navigator Holdings recently experienced unusually high implied volatility in its options market, with significant activity centered around the September 2025 $5.00 Put contract. This surge in options activity, combined with recently upgraded analyst earnings estimates, signals that investors are anticipating a major company event or catalyst. We'll explore how this heightened options market anticipation could influence Navigator Holdings' investment outlook and evolving business...

Verint Systems recently marked its AI achievements by ringing the Nasdaq opening bell, celebrating a nearly 24% growth in AI annual recurring revenue (ARR) in the first quarter of 2025, with AI-driven ARR now comprising almost half of its total ARR. This underscores how Verint's AI solutions, especially its AI-powered bots used by clients like Volaris and BT Group, are enabling greater automation, cost reduction, and new avenues for customer revenue. We'll explore how Verint's rapid...